Puma Biotechnology, Inc. (PBYI) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Puma Biotechnology, Inc.
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage…
Source: Yahoo Finance
Sector & Industry
Puma Biotechnology, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Puma Biotechnology, Inc. at a Glance
| Company | Puma Biotechnology, Inc. |
| Ticker | PBYI |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $9.55 |
| Market cap | $492.97M |
| P/E ratio (trailing) | 18.73 |
| EPS (trailing) | $0.51 |
| 52-week high | $9.74 |
| 52-week low | $4.30 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.23 |
| Return on equity (ROE) | 21.97% |
| Debt-to-equity | 3.48% |
| Average volume | 329,242 |
| Shares outstanding | 51.62M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 179 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Puma Biotechnology, Inc.'s current P/E ratio?
- Puma Biotechnology, Inc. (PBYI) has a trailing P/E ratio of 18.73 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Puma Biotechnology, Inc.'s market capitalisation?
- Puma Biotechnology, Inc.'s market cap is $492.97M based on our latest snapshot. See how it ranks by market cap →
- What is PBYI's 52-week range?
- Over the past 52 weeks, PBYI has traded between $4.30 and $9.74. What does the 52-week range mean? →
- How volatile is Puma Biotechnology, Inc. compared to the market?
- Puma Biotechnology, Inc. has a beta of 1.23, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Puma Biotechnology, Inc. pay a dividend?
- Puma Biotechnology, Inc. does not currently pay a dividend according to our latest data.
- What exchange is PBYI listed on?
- PBYI is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Puma Biotechnology, Inc. in?
- Puma Biotechnology, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →